• Rebecca L Brander, Patricia B Pavlinac, Judd L Walson, Grace C John-Stewart, Marcia R Weaver, Faruque Abu S G ASG International Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh., Zaidi Anita K M AKM Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. P, Dipika Sur, Samba O Sow, M Jahangir Hossain, Pedro L Alonso, Robert F Breiman, Dilruba Nasrin, James P Nataro, Myron M Levine, and Karen L Kotloff.
• Department of Epidemiology, University of Washington, Seattle, WA, USA. rbrander@uw.edu.
• Bmc Med. 2019 Nov 25; 17 (1): 214.

BackgroundModerate-to-severe diarrhea (MSD) in the first 2 years of life can impair linear growth. We sought to determine risk factors for linear growth faltering and to build a clinical prediction tool to identify children most likely to experience growth faltering following an episode of MSD.MethodsUsing data from the Global Enteric Multicenter Study of children 0-23 months old presenting with MSD in Africa and Asia, we performed log-binomial regression to determine clinical and sociodemographic factors associated with severe linear growth faltering (loss of ≥ 0.5 length-for-age z-score [LAZ]). Linear regression was used to estimate associations with ΔLAZ. A clinical prediction tool was developed using backward elimination of potential variables, and Akaike Information Criterion to select the best fit model.ResultsOf the 5902 included children, mean age was 10 months and 43.2% were female. Over the 50-90-day follow-up period, 24.2% of children had severe linear growth faltering and the mean ΔLAZ over follow-up was - 0.17 (standard deviation [SD] 0.54). After adjustment for age, baseline LAZ, and site, several factors were associated with decline in LAZ: young age, acute malnutrition, hospitalization at presentation, non-dysenteric diarrhea, unimproved sanitation, lower wealth, fever, co-morbidity, or an IMCI danger sign. Compared to children 12-23 months old, those 0-6 months were more likely to experience severe linear growth faltering (adjusted prevalence ratio [aPR] 1.97 [95% CI 1.70, 2.28]), as were children 6-12 months of age (aPR 1.72 [95% CI 1.51, 1.95]). A prediction model that included age, wasting, stunting, presentation with fever, and presentation with an IMCI danger sign had an area under the ROC (AUC) of 0.67 (95% CI 0.64, 0.69). Risk scores ranged from 0 to 37, and a cut-off of 21 maximized sensitivity (60.7%) and specificity (63.5%).ConclusionYounger age, acute malnutrition, MSD severity, and sociodemographic factors were associated with short-term linear growth deterioration following MSD. Data routinely obtained at MSD may be useful to predict children at risk for growth deterioration who would benefit from interventions.

20 keywords...

hide…